These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26456145)

  • 21. Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model.
    Nagai-Singer MA; Hendricks-Wenger A; Brock RM; Morrison HA; Tupik JD; Coutermarsh-Ott S; Allen IC
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33074250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.
    Abdelaziz DM; Stone LS; Komarova SV
    Breast Cancer Res Treat; 2014 Jan; 143(2):227-37. PubMed ID: 24327332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate tibial loading and treadmill running, but not overloading, protect adult murine bone from destruction by metastasized breast cancer.
    Wang S; Pei S; Wasi M; Parajuli A; Yee A; You L; Wang L
    Bone; 2021 Dec; 153():116100. PubMed ID: 34246808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography characteristics of multiple myeloma and other osteolytic metastatic bone lesions.
    Mutlu U; Balci A; Özsan GH; Özkal S; Şeyhanli A; Özgül HA
    Acta Radiol; 2021 Dec; 62(12):1639-1647. PubMed ID: 33269940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites.
    Abdelaziz DM; Stone LS; Komarova SV
    Breast Cancer Res Treat; 2015 Aug; 153(1):9-20. PubMed ID: 26208488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal μCT/μMR based semiautomated segmentation of rat vertebrae affected by mixed osteolytic/osteoblastic metastases.
    Hojjat SP; Foltz W; Wise-Milestone L; Whyne CM
    Med Phys; 2012 May; 39(5):2848-53. PubMed ID: 22559657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
    Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
    Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.
    Cicek M; Iwaniec UT; Goblirsch MJ; Vrabel A; Ruan M; Clohisy DR; Turner RR; Oursler MJ
    Cancer Res; 2007 Nov; 67(21):10106-11. PubMed ID: 17974950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-based assessment and classification of periacetabular osteolytic lesions: A new method.
    Surace MF; Monestier L; Fagetti A; Ronga M; Cherubino P
    Surg Technol Int; 2012 Dec; 22():285-9. PubMed ID: 23065802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using ImageJ (Fiji) to Analyze and Present X-Ray CT Images of Enamel.
    Brookes SJ
    Methods Mol Biol; 2019; 1922():267-291. PubMed ID: 30838584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of periacetabular osteolytic lesions.
    Howie DW; Neale SD; Martin W; Costi K; Kane T; Stamenkov R; Findlay DM
    J Bone Joint Surg Am; 2012 Aug; 94(16):e1171-6. PubMed ID: 22992823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BoneJ: Free and extensible bone image analysis in ImageJ.
    Doube M; Kłosowski MM; Arganda-Carreras I; Cordelières FP; Dougherty RP; Jackson JS; Schmid B; Hutchinson JR; Shefelbine SJ
    Bone; 2010 Dec; 47(6):1076-9. PubMed ID: 20817052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
    Peyruchaud O; Winding B; Pécheur I; Serre CM; Delmas P; Clézardin P
    J Bone Miner Res; 2001 Nov; 16(11):2027-34. PubMed ID: 11697798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    Yoneda T; Sasaki A; Dunstan C; Williams PJ; Bauss F; De Clerck YA; Mundy GR
    J Clin Invest; 1997 May; 99(10):2509-17. PubMed ID: 9153295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-CT evaluation of bone defects: applications to osteolytic bone metastases, bone cysts, and fracture.
    Buie HR; Bosma NA; Downey CM; Jirik FR; Boyd SK
    Med Eng Phys; 2013 Nov; 35(11):1645-50. PubMed ID: 23830560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease.
    Hofgaard PO; Jodal HC; Bommert K; Huard B; Caers J; Carlsen H; Schwarzer R; Schünemann N; Jundt F; Lindeberg MM; Bogen B
    PLoS One; 2012; 7(12):e51892. PubMed ID: 23284805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice.
    Winding B; NicAmhlaoibh R; Misander H; Høegh-Andersen P; Andersen TL; Holst-Hansen C; Heegaard AM; Foged NT; Brünner N; Delaissé JM
    Clin Cancer Res; 2002 Jun; 8(6):1932-9. PubMed ID: 12060638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo.
    Lemieux P; Harvey J; Guise T; Dallas M; Oesterreich S; Yin Jj; Selander K; Fuqua S
    J Bone Miner Res; 1999 Sep; 14(9):1570-5. PubMed ID: 10469286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.